News & Publications

News & insights

Corporate team advises AI spin out on Series A investment
Posted: 20/11/2020
The corporate team at Penningtons Manches Cooper has advised Mind Foundry, an Oxford-based artificial intelligence company, on its Series A investment. The funding round, which closed at over £10 million, was led by Aioi Nissay Dowa Insurance (ANDI) of the MS&AD Insurance Group and brings Mind Foundry’s...…>>
Penningtons Manches Cooper advises Oxford University’s 200th spin-out company
Posted: 10/11/2020
Penningtons Manches Cooper’s corporate team has advised cyber security specialist PhishAR, as it becomes the 200th company created through Oxford University Innovation (OUI), the commercialisation arm of Oxford University......>>
Penningtons Manches Cooper advises Bramble Energy on £5 million funding round to support development of pioneering technology
Posted: 28/08/2020
Penningtons Manches Cooper’s corporate team has advised London-based hydrogen fuel cell company Bramble Energy on its £5 million Series A funding round. The round was led by BGF with additional investment from existing investors IP Group, Parkwalk Advisors, and UCL Technology Fund......>>
Penningtons Manches Cooper acts for PQShield on £5.5 million seed funding
Posted: 10/07/2020
The corporate team at Penningtons Manches Cooper has advised Oxford University spin-out PQShield on a £5.5 million seed funding raise......>>
Corporate team advises University of Oxford spin-out Opsydia on £1.9 million funding round for diamond security technology
Posted: 08/06/2018
The corporate team at Penningtons Manches has advised Oxford based Opsydia Limited on its £1.9 million funding from Oxford Sciences Innovation and Parkwalk and subsequent agreement with leading diamond dealers, De Beers......>>

Read all technology transfer and spin-outs news & insights

Publications

Brochures & factsheets

Academic spinouts - a report on the funding of UK spinouts
This report from Penningtons Manches builds on work begun in Financing Growth in Innovative Firms, the consultation published as part of the Patient Capital Review. That report identified growing levels of investment into spinouts in the UK in the context of a perceived dearth of capital available on patient terms.

Return to Technology transfer and spin-outs

In this section

Media enquiries

Contact our press team on:

+44 (0)20 7457 3258
+44 (0)7887 888105 (out of hours)

Useful links

Contact an office

London (Head office)
+44 (0)20 7457 3000
London (Minories)
+44 (0)20 7481 8851
Basingstoke
+44 (0)1256 407100
Birmingham
+44 (0)121 312 2560
Cambridge
+44 (0)1223 465465
Guildford
+44 (0)1483 791800
Oxford
+44 (0)1865 722106
Reading
+44 (0)118 982 2640

Madrid
+34 91 781 6670
Paris
+33 1 44 34 24 80
Piraeus
+30 210 361 4840
São Paulo
+55 11 3750 3600
Singapore
+65 6438 4497

Sectors

Services for Business

Services for Individuals

Copyright

© 2021 Penningtons Manches Cooper LLP.
All rights reserved.
Website design by Frontmedia / Dynamic Pear

Penningtons Manches Cooper LLP

Penningtons Manches Cooper LLP is a limited liability partnership registered in England and Wales with registered number OC311575 and is authorised and regulated by the Solicitors Regulation Authority.